GeoVax (GOVX) Surges 256%, With 207 Million Shares Trading!
What an Entertaining Week!
..and it's only Thursday.
LIVE QUOTE
(MAY 18TH)
(MAY 21ST)
So Where Does That Leave us Today?
Yes, it was a pleasant surprise to see GeoVax...
Americore (AMCOF) Funding Launched. Looks Like Good Entry Point.
All Systems Go?
A recently completed Magnetometer survey sends a strong signal to investors that the company is advancing its project in a disciplined, data-driven...
Cabaletta (CABA) Surges 44% on Massive Volume Spike.
Biotech 12 Pack Off to Nice Start..
Cabaletta up 35%, GeoVax up 75%, and Replimune up 62%. All since late April!
Biotech Stock Review is...
GeoVax (GOVX) Surges 51% on Massive Volume Spike.
MonkeyPox and Gedeptin Related News Spark New Investor Interest.
MARKET BRIEF
On a quiet Wednesday afternoon, the 29th, while we were nearing completion of an updated...
Paving Past Obstacles on the Path to US Biosecurity
GeoVax’s CEO calls on government support to bolster domestic biotechnology and keep pace with China.
National biosecurity has become a frequent topic of conversation in...
All Bases Loaded. Home Run Hitter Ray Palumbo, former Deputy Commanding General of the United...
Four of the Most Powerful and Well Recognized, US Government Intelligence and Defense Experts, Have Officially Joined Forces With Tiny Sekur Private Data (SWISF)...
GeoVax (GOVX) Reports 2025 Year-End Financial Results and Provides Business Update
LIVE QUOTE
Pivotal Phase 3 Trial for GEO-MVA (Mpox/Smallpox Vaccine)
Scheduled to Initiate During the Second Half of This Year
ATLANTA, GA - April 15, 2026 (NEWMEDIAWIRE)...
Danger Will Robinson: the NIPAH Virus with a 40-75% Death Rate Lurks.
Report: Nipah Virus Vaccine: Need, Development Landscape, and $3 Billion Market Opportunity
Report: Nipah Virus Vaccine: Need, Development Landscape, and $3 Billion Market Opportunity
Click to...
Report: AI Powered Review on GeoVax (GOVX) $1.15
In our view, a research report is designed to gather information on publicly traded companies from press releases, management presentations (including power points), SEC...
Biotech Stock Review is Back! Timing Feels Perfect. 4 Companies Added to Watch List.
Biotech 12 Pack Watch List to be Released.
Cabaletta (CABA) $3.07, GeoVax (GOVX) $1.14, PolyPid (PYPD) $4.68, Replimune (REPL) $2.17.
In 2020, we Released the "Biotech...
Latest article
GeoVax (GOVX) Conference Call and Transcript.
Excellent Presentation. You Can Listen for 40 Minutes, or Read it in About Ten, Halleluiah.
Guess what we'll choose to do?
For the life...
Sekur Private Data (SWISF) Awarded Distribution Agreement With Elyon International.
Top Ranked Defense, Government and Enterprise Contractor
Trying to Break Over $0.06.
We are still sitting on the edge of our seat waiting for contract news,...
Broker Dealer – AtlasClear (ATCH) Conference Call
"AtlasClear is being built as an integrated financial services platform that will bring capital markets origination, clearing, and banking together under a single architecture."...
